日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Randomized Controlled Trial

DRL-曲妥珠单抗与赫赛汀治疗人表皮生长因子受体2阳性转移性乳腺癌的疗效、安全性、药代动力学和免疫原性：一项随机对照试验

期刊:JCO Global Oncology
影响因子:3
doi:10.1200/GO.22.00328
Reddy, Naveen; Reddy, Pramod; Ranpura, Ankit; Maharaj, Narendra; Arora, Rajendersingh; Mamillapalli, Gopichand; Adhav, Aditya Shirish; Diwan, Ashok Kumar; Manikhas, Alexey; Krasnozhon, Dmitriy
Human
发表日期：2024
文献求助 收藏

Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial

CT-P6 或参考曲妥珠单抗治疗 HER2 阳性早期乳腺癌患者的六年生存结果：一项 3 期随机对照试验的观察性随访研究

期刊:BioDrugs
影响因子:6.9
doi:10.1007/s40259-023-00582-w
Stebbing, Justin; Baranau, Yauheni; Baryash, Valery; Moiseyenko, Vladimir; Boliukh, Dmytro; Antone, Nicoleta; Manikhas, Alexey; Chornobai, Anatolii; Park, Taehong; Baek, Eric Hyungseok; Lee, Jaeyong; Choi, Jiin; Kim, Nahyun; Ahn, Keumyoung; Lee, Sang Joon; Kim, Sunghyun
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting

一项比较HD201与曲妥珠单抗（作为参照）治疗ERBB2阳性乳腺癌新辅助治疗患者的3期随机临床试验的最终分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-023-10574-2
Pivot, Xavier; Manikhas, Alexey Georgievitch; Shamrai, Volodymyr; Dzagnidze, Giorgi; Soo Hoo, Hwoei Fen; Kaewkangsadan, Viriya; Petrelli, Fausto; Villanueva, Cristian; Kim, Jamie; Pradhan, Sumita; Jaison, Litha; Feyaerts, Peggy; Kaufman, Leonard; Derde, Marie-Paule; Deforce, Filip; Cox, David G
ERBB2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

B Lymphocytes Are a Predictive Marker of Eribulin Response and Overall Survival in Locally Advanced or Metastatic Breast Cancer: A Multicenter, Two-Cohort, Non-Randomized, Open-Label, Retrospective Study

B淋巴细胞是局部晚期或转移性乳腺癌患者对艾立布林治疗反应和总生存期的预测标志物：一项多中心、双队列、非随机、开放标签、回顾性研究

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.909505
Tashireva, Liubov A; Popova, Nataliya O; Kalinchuk, Anna Yu; Goldberg, Viktor E; Kovalenko, Elena I; Artamonova, Elena V; Manikhas, Aleksey G; Ponomarenko, Dmitriy M; Levchenko, Nataliya V; Rossokha, Elena I; Krasilnikova, Svetlana Yu; Zafirova, Marina A; Choynzonov, Evgeniy L; Perelmuter, Vladimir M
细胞生物学
肿瘤
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR + , HER2- metastatic breast cancer

nextMONARCH II期随机临床试验：阿贝西利单药治疗或联合他莫昔芬治疗内分泌难治性HR+、HER2-转移性乳腺癌患者的总生存期分析

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-022-06662-9
Hamilton, Erika; Cortes, Javier; Ozyilkan, Ozgur; Chen, Shin-Cheh; Petrakova, Katarina; Manikhas, Aleksey; Jerusalem, Guy; Hegg, Roberto; Huober, Jens; Zhang, Wei; Chen, Yanyun; Martin, Miguel
肿瘤
HER2
肿瘤免疫
乳腺癌
ARC
发表日期：2022
文献求助 收藏

Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis

新鲜和冷冻保存的卵巢组织移植在保存生殖和内分泌功能方面的应用：系统评价和个体患者数据荟萃分析

期刊:Human Reproduction Update
影响因子:
doi:10.1093/humupd/dmac003
Khattak, Hajra; Malhas, Rosamund; Craciunas, Laurentiu; Afifi, Yousri; Amorim, Christiani A; Fishel, Simon; Silber, Sherman; Gook, Debra; Demeestere, Isabelle; Bystrova, Olga; Lisyanskaya, Alla; Manikhas, Georgy; Lotz, Laura; Dittrich, Ralf; Colmorn, Lotte Berdiin; Macklon, Kirsten Tryde; Hjorth, Ina Marie Dueholm; Kristensen, Stine Gry; Gallos, Ioannis; Coomarasamy, Arri
发表日期：2022
文献求助 收藏

Correction to: Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis

更正：新鲜和冷冻保存的卵巢组织移植用于保存生殖和内分泌功能：系统评价和个体患者数据荟萃分析

期刊:Human Reproduction Update
影响因子:
doi:10.1093/humupd/dmac015
Khattak, Hajra; Malhas, Rosamund; Craciunas, Laurentiu; Afifi, Yousri; Amorim, Christiani A; Fishel, Simon; Silber, Sherman; Gook, Debra; Demeestere, Isabelle; Bystrova, Olga; Lisyanskaya, Alla; Manikhas, Georgy; Lotz, Laura; Dittrich, Ralf; Colmorn, Lotte Berdiin; Macklon, Kirsten Tryde; Hjorth, Ina Marie Dueholm; Kristensen, Stine Gry; Gallos, Ioannis; Coomarasamy, Arri
发表日期：2022
文献求助 收藏

Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer

HERITAGE III期研究的最终总生存期分析表明，在HER2阳性转移性乳腺癌中，曲妥珠单抗-dkst与曲妥珠单抗疗效相当。

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06197-5
Rugo, Hope S; Pennella, Eduardo J; Gopalakrishnan, Unmesh; Hernandez-Bronchud, Miguel; Herson, Jay; Koch, Hans Friedrich; Loganathan, Subramanian; Deodhar, Sarika; Marwah, Ashwani; Manikhas, Alexey; Bondarenko, Igor; Mukhametshina, Guzel; Nemsadze, Gia; Parra, Joseph D; Abesamis-Tiambeng, Maria Luisa T; Baramidze, Kakhaber; Akewanlop, Charuwan; Vynnychenko, Ihor; Sriuranpong, Virote; Mamillapalli, Gopichand; Roy, Sirshendu; Yanez Ruiz, Eduardo Patricio; Barve, Abhijit; Fuentes-Alburo, Adolfo; Waller, Cornelius F
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial

CT-P6 与曲妥珠单抗治疗 HER2 阳性早期乳腺癌患者的长期疗效和安全性：一项随机 III 期试验的最终结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-021-06240-5
Stebbing, Justin; Baranau, Yauheni V; Baryash, Valery; Manikhas, Alexey; Moiseyenko, Vladimir; Dzagnidze, Giorgi; Zhavrid, Edvard; Boliukh, Dmytro; Pikiel, Joanna; Eniu, Alexandru E; Li, Rubi K; Tiangco, Beatrice; Lee, Sang Joon; Kim, Sunghyun
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2021
文献求助 收藏

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer

非聚乙二醇化脂质体阿霉素联合曲妥珠单抗和紫杉醇治疗HER2阳性转移性乳腺癌的III期临床试验

期刊:Annals of Oncology
影响因子:65.4
doi:10.1093/annonc/mdy529
Baselga, J; Manikhas, A; Cortés, J; Llombart, A; Roman, L; Semiglazov, V F; Byakhov, M; Lokanatha, D; Forenza, S; Goldfarb, R H; Matera, J; Azarnia, N; Hudis, C A; Rozencweig, M
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏